Milestone Scientific (MLSS) Q2 2026 Earnings Call: Revenue Up 22%, Guidance Reaffirmed
Source Tradingkey
Key Takeaways
- Q2 2026 revenue increased 22% year over year to $2.8 million, while first-half revenue rose 9.8% to $5.0 million.
- Medical segment revenue grew 231% from Q2 2025, supported by early-stage adoption of CompuFlo.
- Q2 gross margin declined to 67.2% from 69.6%, reflecting product and customer mix, tariffs, and higher costs for certain imported products and components.
- The company reaffirmed its 2026 revenue guidance of $9.8 million to $10.2 million. Management expects CompuFlo to grow faster than the overall business during the remainder of the year.
- Management projected Q3 revenue of $2.3 million to $2.5 million, citing normal summer seasonality and the expected nonrecurrence of two large international dental orders that benefited Q2.
- Medicare payment of $325 has been established under Novitas and First Coast fee schedules across three jurisdictions and 13 states, representing approximately 30% to 35% of the U.S. population, according to management.
Key Financial Results
| Metric | Q2 2026 | Q2 2025 | Change / Commentary |
|---|---|---|---|
| Revenue | $2.8 million | Approximately $2.3 million | Up 22% |
| Gross profit | $1.9 million | $1.6 million | Higher sales partially offset cost pressure |
| Gross margin | 67.2% | 69.6% | Lower due to mix and increased product costs |
| Operating expenses | Approximately $3.0 million | Approximately $3.1 million | Down 4.2% |
| Net loss | $1.1 million | $1.5 million | Loss narrowed by approximately $0.4 million |
| Medical segment revenue growth | — | — | Up 231% year over year |
| Metric | H1 2026 | H1 2025 | Change |
|---|---|---|---|
| Revenue | $5.0 million | $4.6 million | Up $447,000, or 9.8% |
| Gross profit | $3.5 million | $3.3 million | Increased year over year |
| Gross margin | 69.4% | 71.0% | Down 1.6 percentage points |
| Operating expenses | Approximately $5.4 million | Approximately $6.7 million | Down approximately $1.4 million, or 20% |
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
Elon Musk owns 48.4% of SpaceX (SPCX) on paper. What he owns outright today is closer to 36%, or roughly $708 billion.Friday’s headlines put the stakes at over $900 billion. Musk replied that the numb
Peter Schiff picked the 55th anniversary of America’s break with gold to make a blunt case. The 1971 decision, he argues, is why the dollar is in trouble today.Schiff is a founding member of Euro Paci
Greg Abel became the successor to Warren Buffett when he took over the famous investment firm Berkshire Hathaway in January 2026. Although he doesn’t publish stock tips, Berkshire Hathaway’s latest po
Nike (NKE) closed at $39.09 on Monday. That is its weakest close since September 2014. The stock sits about 78% below its 2021 record. Bitcoin has not fallen that far in this bear market.Nike is a Dow
Three straight years of double-digit gains have not raised the odds of a Dow Jones Industrial Average pullback. That is the conclusion of MarketWatch contributor Mark Hulbert. The Dow’s historical bas
